Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.
about
Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma.Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model.Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristineLiposome size and charge optimization for intraarterial delivery to gliomas.Secretory phospholipase A₂ responsive liposomes.Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging.Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer ModelUniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.Systems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacyMechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation.Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.Novel drug-delivery approaches to the blood-brain barrier.Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models.Preclinical studies of pegylated- and non-pegylated liposomal forms of doxorubicin as radiosensitizer on orthotopic high-grade glioma xenografts.Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.Effective delivery of chemotherapeutic nanoparticles by depleting host Kupffer cells.Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumors.Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
P2860
Q27300391-20AF7A67-484C-43E4-8A07-FDAB0FE17E56Q30385033-02CE60A2-1ADE-4A12-B4D6-DACA329973EBQ30388067-D4A1C872-507B-4740-8392-745AD10EC9E2Q30435074-2B904DF9-9B11-4E35-8649-B19171D6B92EQ33423926-9361FC0A-1F9E-4413-B28C-11D2B59603AAQ33613579-1A748FBB-C89A-4A02-BF59-CCC2F85B4B92Q33866374-DF3534F4-B003-4492-A388-232D780BB7CDQ33901718-0DD8765A-BCE1-4CA7-9D2B-804FBA104932Q35385515-B7B1406B-0A01-48D6-AA2E-6B2C24B1E609Q35972521-16BF558D-300C-47EB-8827-37CAF8D4E890Q36447756-0BD043E4-A7F2-421F-9D7A-B3D6047003A1Q36454892-62CE24C9-B707-4453-9275-CB383EA3C553Q36497582-ED9DA5A7-83F8-4202-A723-111462D4A855Q36782265-5B33AC34-B9D3-484A-A7FE-0DECD3DBF845Q37689857-CF964D39-0AB9-40AB-9655-ABF0F14A8F0CQ38321195-351941A2-A121-4140-8B21-0FD6BF440316Q38959672-902E9ED7-2AB7-47D3-A3D0-06CF692C2C2BQ38962673-E7B22091-48B8-48F1-8507-7474B2D1C4DCQ38973056-ACD09D41-31C6-4B44-8915-57598D0F8D5BQ39297921-291F84D7-A7C5-4985-9B30-10B292D026A4Q39391031-766D4BCB-176F-40CD-BAE6-6D0B93A9980CQ46002668-37C13D41-833D-42CE-983A-9DDEC2F6DAF3Q59133970-D1826028-5AB8-49CA-864D-0AC86DF5B8E5
P2860
Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Effect of repetitive administr ...... on in a rat brain tumor model.
@ast
Effect of repetitive administr ...... on in a rat brain tumor model.
@en
type
label
Effect of repetitive administr ...... on in a rat brain tumor model.
@ast
Effect of repetitive administr ...... on in a rat brain tumor model.
@en
prefLabel
Effect of repetitive administr ...... on in a rat brain tumor model.
@ast
Effect of repetitive administr ...... on in a rat brain tumor model.
@en
P2093
P2860
P1476
Effect of repetitive administr ...... ion in a rat brain tumor model
@en
P2093
Donald E Mager
Jeanine E Slack
Robert M Straubinger
P2860
P304
P356
10.1158/1078-0432.CCR-05-1365
P407
P433
P577
2005-12-01T00:00:00Z